Results 301 to 310 of about 10,439,347 (402)

Time preferences and food choices: Evidence from a choice experiment

, 2016
E. Marchi, Vincenzina Caputo, R. Nayga, A. Banterle   +3 more
semanticscholar   +1 more source

Oncologists' preferences for first-line treatment of ALK-positive metastatic NSCLC in the United States: a discrete choice experiment. [PDF]

Future Oncol
Mileham KF, Panattoni L, Gahlon G, Labisa P, Bariahtaris N, Graf M, Danes C, Hernandez L.   +7 more
europepmc   +1 more source

Preferences for coordinated care for rare diseases: discrete choice experiment [PDF]

Stephen Morris, Holly Walton, Amy Simpson, Kerry Leeson‐Beevers, Lara Bloom, Amy Hunter, Angus I. G. Ramsay, Naomi Fulop, Lyn S. Chitty, Joe Kai, Alastair Sutcliffe, Maria Kokocinska, Larissa Kerecuk, Christine A. Taylor, Pei Li Ng   +14 more
openalex   +1 more source

Genetic attenuation of ALDH1A1 increases metastatic potential and aggressiveness in colorectal cancer

Molecular Oncology, EarlyView.
Aldehyde dehydrogenase 1A1 (ALDH1A1) is a cancer stem cell marker in several malignancies. We established a novel epithelial cell line from rectal adenocarcinoma with unique overexpression of this enzyme. Genetic attenuation of ALDH1A1 led to increased invasive capacity and metastatic potential, the inhibition of proliferation activity, and ultimately ...
Martina Poturnajova, Zuzana Kozovska, Ondrej Pos, Kristina Pavlov, Sachin Gulati, Peter Makovicky, Kristina Jakic, Monika Burikova, Eva Sedlackova, Barbora Svitkova, Silvia Tyciakova, Vojtech Bystry, Nicolas Blavet, Boris Tichy, Matej Hrnciar, Jaroslav Budis, Miroslav Tomas, Peter Dubovan, Georgina Kolnikova, Veronika Repaska, Nikoleta Mojzesova, Eva Zomborska, Daniel Pindak, Michal Mego, Tomas Szemes, Miroslava Matuskova   +25 more
wiley   +1 more source

Adaptation and pilot testing of a discrete choice experiment and survey on patient preferences for long-acting antiretroviral therapies for HIV in Kenya. [PDF]

AIDS Care
Maina CN, Kaggiah AW, Barthold D, Tran J, Saldarriaga EM, Simoni JM, Hauber B, Kinuthia J, Graham SM.   +8 more
europepmc   +1 more source

Research Proposal: Nudging and disclosure in the field: two experiments on food choice nudges and transparency

Cuypers, Robin, Raymaekers, Pieter, Van de Walle, steven   +2 more
openalex   +1 more source

Targeted modulation of IGFL2‐AS1 reveals its translational potential in cervical adenocarcinoma

Molecular Oncology, EarlyView.
Cervical adenocarcinoma patients face worse outcomes than squamous cell carcinoma counterparts despite similar treatment. The identification of IGFL2‐AS1's differential expression provides a molecular basis for distinguishing these histotypes, paving the way for personalized therapies and improved survival in vulnerable populations globally.
Ricardo Cesar Cintra, Lucca Paolo Hsu Helmich, Daniel Rodrigues de Bastos, Laura Sichero, Patrícia Savio de Araujo‐Souza, Fabio Passetti, Luisa Lina Villa   +6 more
wiley   +1 more source

Patient preference survey for attributes of locally advanced or metastatic urothelial carcinoma treatment in Japan: a discrete-choice experiment. [PDF]

BMJ Open
Kitamura H, Uchida H, Tanaka Y, Akiyama T, Morishita A, Yakushiji A, Sakurai M.   +6 more
europepmc   +1 more source

Dataset and R Script for Visual Discrete Choice Experiments on Pedestrian Crossing Behavior in Ecuador

García_Ramírez, Yasmany
openalex   +1 more source

Homologous expression and purification of human HAX‐1 for structural studies

FEBS Open Bio, EarlyView.
This research protocol provides detailed instructions for cloning, expressing, and purifying large quantities of the intrinsically disordered human HAX‐1 protein, N‐terminally fused to a cleavable superfolder GFP, from mammalian cells. HAX‐1 is predicted to undergo posttranslational modifications and to interact with membranes, various cellular ...
Mariana Grieben
wiley   +1 more source